000 | 01854 a2200493 4500 | ||
---|---|---|---|
005 | 20250517024402.0 | ||
264 | 0 | _c20150703 | |
008 | 201507s 0 0 eng d | ||
022 | _a1096-0333 | ||
024 | 7 |
_a10.1016/j.taap.2015.03.008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDoherty, Kimberly R | |
245 | 0 | 0 |
_aStructural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types. _h[electronic resource] |
260 |
_bToxicology and applied pharmacology _cMay 2015 |
||
300 |
_a51-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xclassification |
650 | 0 | 4 |
_aBiomarkers _xmetabolism |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aHeart Diseases _xchemically induced |
650 | 0 | 4 | _aHigh-Throughput Screening Assays |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInduced Pluripotent Stem Cells _xdrug effects |
650 | 0 | 4 |
_aLipid Metabolism _xdrug effects |
650 | 0 | 4 | _aMolecular Structure |
650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aToxicity Tests _xmethods |
650 | 0 | 4 |
_aTroponin I _xmetabolism |
700 | 1 | _aTalbert, Dominique R | |
700 | 1 | _aTrusk, Patricia B | |
700 | 1 | _aMoran, Diarmuid M | |
700 | 1 | _aShell, Scott A | |
700 | 1 | _aBacus, Sarah | |
773 | 0 |
_tToxicology and applied pharmacology _gvol. 285 _gno. 1 _gp. 51-60 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.taap.2015.03.008 _zAvailable from publisher's website |
999 |
_c24773448 _d24773448 |